{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:34:39Z","timestamp":1770442479030,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03766-y","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:58:04Z","timestamp":1767949084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of a high proportion of cefoperazone\/tazobactam on lung function and bacterial clearance rate in patients with chronic obstructive pulmonary disease and lower respiratory tract infection Klebsiella pneumoniae"],"prefix":"10.1186","volume":"31","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"3766_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","author":"T Raveling","year":"2021","unstructured":"Raveling T, et al. Chronic non-invasive ventilation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3766_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12890-022-02052-5\/TABLES\/5","volume":"22","author":"X Fu","year":"2022","unstructured":"Fu X, et al. Delirium in elderly patients with COPD combined with respiratory failure undergoing mechanical ventilation: a prospective cohort study. BMC Pulm Med. 2022;22(1):1\u20138. https:\/\/doi.org\/10.1186\/S12890-022-02052-5\/TABLES\/5.","journal-title":"BMC Pulm Med"},{"key":"3766_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3089227","author":"X Xiong","year":"2022","unstructured":"Xiong X, Yuan W. \u201cEffect of noninvasive positive pressure ventilation on prognosis and blood gas level in COPD patients complicated with respiratory failure. Evid Based Complement Alternat Med. 2022. https:\/\/doi.org\/10.1155\/2022\/3089227.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"3766_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1164\/RCCM.202301-0106PP\/SUPPL_FILE\/DISCLOSURES.PDF","volume":"207","author":"A Agust\u00ed","year":"2023","unstructured":"Agust\u00ed A, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Am J Respir Crit Care Med. 2023;207(7):819\u201337. https:\/\/doi.org\/10.1164\/RCCM.202301-0106PP\/SUPPL_FILE\/DISCLOSURES.PDF.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3766_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13063-021-05692-W\/FIGURES\/1","volume":"22","author":"T Tonetti","year":"2021","unstructured":"Tonetti T, et al. Extracorporeal carbon dioxide removal for treatment of exacerbated chronic obstructive pulmonary disease (ORION): study protocol for a randomised controlled trial. Trials. 2021;22(1):1\u201310. https:\/\/doi.org\/10.1186\/S13063-021-05692-W\/FIGURES\/1.","journal-title":"Trials"},{"key":"3766_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","author":"S Janjua","year":"2021","unstructured":"Janjua S, et al. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"key":"3766_CR7","doi-asserted-by":"crossref","unstructured":"E. H. Ouaalaya et al. Susceptibility to frequent exacerbation in COPD patients: impact of the exacerbations history, vaccinations and comorbidities? Corresponding author information. 2020","DOI":"10.1016\/j.rmed.2020.106018"},{"key":"3766_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","author":"FM Struik","year":"2013","unstructured":"Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3766_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.MICINF.2019.08.003","volume":"22","author":"TS Jensen","year":"2020","unstructured":"Jensen TS, et al. Complement mediated Klebsiella pneumoniae capsule changes. Microbes Infect. 2020;22(1):19\u201330. https:\/\/doi.org\/10.1016\/J.MICINF.2019.08.003.","journal-title":"Microbes Infect"},{"key":"3766_CR10","doi-asserted-by":"publisher","first-page":"103690","DOI":"10.1016\/J.AMSU.2022.103690","volume":"77","author":"A Kharazmkia","year":"2022","unstructured":"Kharazmkia A, Amirizadeh M, Goudarzi Z, Birjandi M, Barfipoursalar A, Mir S. Prevalence of K. pneumoniaeC-producing bacteria in negative gram of clinical samples obtained from patients. Ann Med Surg (Lond). 2022;77:103690. https:\/\/doi.org\/10.1016\/J.AMSU.2022.103690.","journal-title":"Ann Med Surg (Lond)"},{"issue":"12","key":"3766_CR11","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/S10096-019-03673-1","volume":"38","author":"F Hu","year":"2019","unstructured":"Hu F, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275\u201381. https:\/\/doi.org\/10.1007\/S10096-019-03673-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3766_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/S12890-019-0864-0","author":"Z Zha","year":"2019","unstructured":"Zha Z, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in Anhui Province, China: a population-based survey. BMC Pulm Med. 2019. https:\/\/doi.org\/10.1186\/S12890-019-0864-0.","journal-title":"BMC Pulm Med"},{"key":"3766_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS12030479\/S1","author":"M Horv\u00e1th","year":"2023","unstructured":"Horv\u00e1th M, et al. Virulence characteristics and molecular typing of carbapenem-resistant ST15 klebsiella pneumoniae clinical isolates, possessing the K24 capsular type. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/ANTIBIOTICS12030479\/S1.","journal-title":"Antibiotics"},{"key":"3766_CR14","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/IDR.S453025","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Kumar S, Zhang L. Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect Drug Resist. 2024;17:1107. https:\/\/doi.org\/10.2147\/IDR.S453025.","journal-title":"Infect Drug Resist"},{"key":"3766_CR15","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.2147\/IDR.S371477","volume":"15","author":"Z Sheng","year":"2022","unstructured":"Sheng Z, et al. Clinical and microbiological characteristics of Klebsiella pneumoniae bloodstream infection in a Chinese hospital: hypervirulent and multiclonal. Infect Drug Resist. 2022;15:3981\u201390. https:\/\/doi.org\/10.2147\/IDR.S371477.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"3766_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1556\/030.2023.02186","volume":"70","author":"B Kocsis","year":"2023","unstructured":"Kocsis B. Hypervirulent Klebsiella pneumoniae: an update on epidemiology, detection and antibiotic resistance. Acta Microbiol Immunol Hung. 2023;70(4):278\u201387. https:\/\/doi.org\/10.1556\/030.2023.02186.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"1","key":"3766_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/J.DIAGMICROBIO.2019.04.008","volume":"95","author":"H Namikawa","year":"2019","unstructured":"Namikawa H, et al. Clinical characteristics of bacteremia caused by hypermucoviscous Klebsiella pneumoniae at a tertiary hospital. Diagn Microbiol Infect Dis. 2019;95(1):84\u20138. https:\/\/doi.org\/10.1016\/J.DIAGMICROBIO.2019.04.008.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3766_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/S40659-024-00485-2","author":"M G\u00e1lvez-Silva","year":"2024","unstructured":"G\u00e1lvez-Silva M, et al. Carbapenem-resistant hypervirulent ST23 Klebsiella pneumoniae with a highly transmissible dual-carbapenemase plasmid in Chile. Biol Res. 2024. https:\/\/doi.org\/10.1186\/S40659-024-00485-2.","journal-title":"Biol Res"},{"issue":"1","key":"3766_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13073-019-0706-Y\/TABLES\/5","volume":"12","author":"KL Wyres","year":"2020","unstructured":"Wyres KL, et al. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med. 2020;12(1):1\u201316. https:\/\/doi.org\/10.1186\/S13073-019-0706-Y\/TABLES\/5.","journal-title":"Genome Med"},{"key":"3766_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2022.996753","author":"Z He","year":"2022","unstructured":"He Z, et al. Epidemiological characteristics an outbreak of ST11 multidrug-resistant and hypervirulent Klebsiella pneumoniae in Anhui, China. Front Microbiol. 2022. https:\/\/doi.org\/10.3389\/FMICB.2022.996753.","journal-title":"Front Microbiol"},{"key":"3766_CR21","doi-asserted-by":"publisher","first-page":"1003783","DOI":"10.3389\/FMICB.2022.1003783\/BIBTEX","volume":"13","author":"YL Han","year":"2022","unstructured":"Han YL, et al. Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2022;13:1003783. https:\/\/doi.org\/10.3389\/FMICB.2022.1003783\/BIBTEX.","journal-title":"Front Microbiol"},{"issue":"2","key":"3766_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS9020077","volume":"9","author":"MJ Sheu","year":"2020","unstructured":"Sheu MJ, et al. In vitro antimicrobial activity of various cefoperazone\/sulbactam products. Antibiotics. 2020;9(2):77. https:\/\/doi.org\/10.3390\/ANTIBIOTICS9020077.","journal-title":"Antibiotics"},{"key":"3766_CR23","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.2147\/IDR.S313828","volume":"14","author":"CH Chen","year":"2021","unstructured":"Chen CH, et al. Clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia. Infect Drug Resist. 2021;14:2251. https:\/\/doi.org\/10.2147\/IDR.S313828.","journal-title":"Infect Drug Resist"},{"issue":"22","key":"3766_CR24","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3760\/CMA.J.ISSN.0376-2491.2019.22.003","volume":"99","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, et al. Diagnostic value of HBP, PCT combined with APACHE \u2161 score respectively in ventilator-associated pneumonia. Zhonghua Yi Xue Za Zhi. 2019;99(22):1698\u2013702. https:\/\/doi.org\/10.3760\/CMA.J.ISSN.0376-2491.2019.22.003.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"7","key":"3766_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/THX.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581\u20136. https:\/\/doi.org\/10.1136\/THX.54.7.581.","journal-title":"Thorax"},{"issue":"8","key":"3766_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1164\/rccm.201807-1374OC","volume":"199","author":"S Raju","year":"2019","unstructured":"Raju S, et al. Rural residence and poverty are independent risk factors for chronic obstructive pulmonary disease in the United States. Am J Respir Crit Care Med. 2019;199(8):961\u20139. https:\/\/doi.org\/10.1164\/rccm.201807-1374OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3766_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/J.CCM.2020.05.002","volume":"41","author":"L Ruvuna","year":"2020","unstructured":"Ruvuna L, Sood A. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):315\u201327. https:\/\/doi.org\/10.1016\/J.CCM.2020.05.002.","journal-title":"Clin Chest Med"},{"issue":"2","key":"3766_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/J.CANLET.2016.09.002","volume":"382","author":"C Mouronte-Roib\u00e1s","year":"2016","unstructured":"Mouronte-Roib\u00e1s C, Leiro-Fern\u00e1ndez V, Fern\u00e1ndez-Villar A, Botana-Rial M, Ramos-Hern\u00e1ndez C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett. 2016;382(2):240\u20134. https:\/\/doi.org\/10.1016\/J.CANLET.2016.09.002.","journal-title":"Cancer Lett"},{"issue":"13","key":"3766_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/JCM10132889","volume":"10","author":"K Szalontai","year":"2021","unstructured":"Szalontai K, et al. Chronic obstructive pulmonary disease: epidemiology, biomarkers, and paving the way to lung cancer. J Clin Med. 2021;10(13):2889. https:\/\/doi.org\/10.3390\/JCM10132889.","journal-title":"J Clin Med"},{"key":"3766_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2147\/COPD.S360222","volume":"17","author":"H Seo","year":"2022","unstructured":"Seo H, et al. The relationship between comorbidities and microbiologic findings in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2022;17:855\u201367. https:\/\/doi.org\/10.2147\/COPD.S360222.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"52","key":"3766_CR31","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1016\/J.VACCINE.2020.11.004","volume":"38","author":"Y Sun","year":"2020","unstructured":"Sun Y, et al. Incidence of community-acquired pneumonia in urban China: a national population-based study. Vaccine. 2020;38(52):8362\u201370. https:\/\/doi.org\/10.1016\/J.VACCINE.2020.11.004.","journal-title":"Vaccine"},{"issue":"3","key":"3766_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/1120009X.2020.1730087","volume":"32","author":"E Guclu","year":"2020","unstructured":"Guclu E, Kaya G, Ogutlu A, Karabay O. The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections. J Chemother. 2020;32(3):118\u201323. https:\/\/doi.org\/10.1080\/1120009X.2020.1730087.","journal-title":"J Chemother"},{"key":"3766_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.JGAR.2019.01.029","volume":"18","author":"CZ Hua","year":"2019","unstructured":"Hua CZ, et al. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin\/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: a single-centre study in Zhejiang Province, China. J Glob Antimicrob Resist. 2019;18:47\u201351. https:\/\/doi.org\/10.1016\/J.JGAR.2019.01.029.","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"3766_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/CID\/CIW243","volume":"63","author":"D van Duin","year":"2016","unstructured":"van Duin D, Bonomo RA. Ceftazidime\/Avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations. Clin Infect Dis. 2016;63(2):234\u201341. https:\/\/doi.org\/10.1093\/CID\/CIW243.","journal-title":"Clin Infect Dis"},{"key":"3766_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052737","volume":"11","author":"M Sharma","year":"2021","unstructured":"Sharma M, Baghel R, Thakur S, Adwal S. Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study. BMJ Open. 2021;11:52737. https:\/\/doi.org\/10.1136\/bmjopen-2021-052737.","journal-title":"BMJ Open"},{"issue":"6","key":"3766_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/1120009X.2022.2153314","volume":"35","author":"X Chong","year":"2023","unstructured":"Chong X, Wang L, Hu C, He L. Quality control and consistency evaluation of ceftriaxone sodium for injection. J Chemother. 2023;35(6):477\u201390. https:\/\/doi.org\/10.1080\/1120009X.2022.2153314.","journal-title":"J Chemother"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03766-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:42:00Z","timestamp":1770388920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03766-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03766-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Quzhou People's Hospital. All methods were carried out in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors confirming that WRITTEN INFORMED consent was obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}